IL17A and neoplasm: Acute IL-17 signaling can enhance anti-tumor immunity by recruiting neutrophils and promoting inflammation, yet chronic IL-17 exposure fosters immune tolerance, angiogenesis, and stromal remodeling, ultimately contributing to tumor progression and metastasis.